Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the...
Covered in this story
What has happened since
- Edwards Lifesciences is up 1.5% since this was published, 42 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Edwards Lifesciences
- TD Cowen: $84.5 → $104 by Jul 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $EW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Edwards Lifesciences →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.